Growth Metrics

Bio-Techne (TECH) Gains from Sales and Divestitures (2016 - 2025)

Bio-Techne has reported Gains from Sales and Divestitures over the past 10 years, most recently at $134000.0 for Q2 2025.

  • Quarterly results put Gains from Sales and Divestitures at $134000.0 for Q2 2025, up 346.67% from a year ago — trailing twelve months through Jun 2025 was $134000.0 (up 346.67% YoY), and the annual figure for FY2025 was $134000.0, up 346.67%.
  • Gains from Sales and Divestitures for Q2 2025 was $134000.0 at Bio-Techne, up from $30000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for TECH hit a ceiling of $206000.0 in Q2 2021 and a floor of $30000.0 in Q2 2024.
  • Median Gains from Sales and Divestitures over the past 5 years was $134000.0 (2025), compared with a mean of $127600.0.
  • Biggest five-year swings in Gains from Sales and Divestitures: crashed 75.61% in 2024 and later skyrocketed 346.67% in 2025.
  • Bio-Techne's Gains from Sales and Divestitures stood at $206000.0 in 2021, then dropped by 29.61% to $145000.0 in 2022, then fell by 15.17% to $123000.0 in 2023, then crashed by 75.61% to $30000.0 in 2024, then skyrocketed by 346.67% to $134000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $134000.0 (Q2 2025), $30000.0 (Q2 2024), and $123000.0 (Q2 2023) per Business Quant data.